Taste Evaluation of Different Liquid Formulations With Eliglustat

Completed · Phase 1

Conditions studied: Gaucher Disease

In brief

Primary Objective: The purpose of this study is to assess the palatability of eliglustat prototype liquid formulations in healthy subjects.

Key facts

Study ID

NCT02422654

Run by

Genzyme, a Sanofi Company

People needed

8

Starts

2015-04-01

Expected to finish

2015-05-01

Last updated by the study team

2015-05-27

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy male and female subjects, 18 to 55 years of age, inclusive.
• Normal smell and taste ability to discriminate odor and flavor differences.

You may not qualify if…

• Poor metabolizer phenotype status for CYP2D6 (predicted based on genotype).
• Subject who has smoked within 3 months of inclusion.
• The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Where it is running

• Investigational Site Number 840001 — Evansville, Indiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.